GH1 and breast cancer: Intracellular (autocrine) GH promotes breast cancer cell transformation (292, 294, 301, 307, 308) and induces an invasive phenotype by triggering an epithelial–mesenchymal transition (EMT), cell motility, and increased cell survival (295, 297, 300–302).